Products Name |
Cat.No. |
Animal Type |
Disease Area |
Seizures, pentylenetetrazol-induced, in monkey (Cynomolgus)
|
AB242893 |
Cynomolgus monkey |
Seizures |
Seizures, pentylenetetrazole-induced, in monkey (Cynomolgus)
|
AB242894 |
Cynomolgus monkey |
Seizures |
Sepsis, Escherichia coli-induced, in monkey (Cynomolgus)
|
AB242895 |
Cynomolgus monkey |
Sepsis |
Serotonin transporter (SERT; 5-HTT) activation, neonatal maternal deprivation-induced, in monkey (Rhesus)
|
AB242896 |
Rhesus monkey |
|
Serotonin transporter (SERT; 5-HTT) affinity, in monkey (Cynomolgus)
|
AB242897 |
Cynomolgus monkey |
|
Severe acute respiratory syndrome coronavirus (SARS-CoV) infection, severe acute respiratory syndrome coronavirus-induced, in monkey
|
AB242898 |
not specified |
Severe acute respiratory syndrome coronavirus (SARS-CoV) infection |
Severe acute respiratory syndrome coronavirus (SARS-CoV) infection, severe acute respiratory syndrome coronavirus-induced, in monkey (Rhesus)
|
AB242899 |
Rhesus monkey |
Severe acute respiratory syndrome coronavirus (SARS-CoV) infection |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19), coronavirus (COVID-19; 2019-nCoV (B1.351 variant))-induced, in monkey (Rhesus)
|
AB242900 |
Rhesus monkey |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19), coronavirus (COVID-19; 2019-nCoV) (B.1.1.529)-induced, in monkey (Rhesus)
|
AB242901 |
Rhesus monkey |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19), coronavirus (COVID-19; 2019-nCoV) (D614G-mutated)-induced, in monkey (Rhesus)
|
AB242902 |
Rhesus monkey |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) |